Background {#Sec1}
==========

Osteoporosis (OP) is one of the commonly seen bone diseases with low bone mineral densities and trauma fractures \[[@CR12], [@CR13]\]. A large population suffers from OP, therefore, it possesses a great burden on both public health and the economy \[[@CR18]\]. Accumulative studies have demonstrated that the occurrence of OP is closely related to osteoclasts differentiation \[[@CR26]\]. In recent years, long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) are attracting more and more interest. These two non-coding RNAs may contribute to the dysregulated osteoclasts differentiation \[[@CR8]\]. Therefore, biologists are paying more effort in the study of lncRNAs and miRNAs in the diagnostics, treatment directions, and prognostics for patients with OP.

LncRNAs are a group of RNA molecules with lengths of over 200 nucleotides, while they cannot be translated to proteins \[[@CR11]\]. There is growing evidence suggesting that lncRNAs act as essential roles in a series of biological procedures including transcriptional regulations, cell apoptosis, as well as tumorigenesis \[[@CR2], [@CR6]\]. For OP, lncRNAs were proved to participate in the differentiation of osteoclasts. Long non-coding RNA FTX is a conserved functional lncRNA that could encode in the X-inactivation center \[[@CR28]\]. LncRNA FTX has been demonstrated to inhibit the development of hepatocellular carcinoma \[[@CR28]\], cardiomyocyte \[[@CR17]\], and colorectal cancer \[[@CR7]\]. However, its potential functions in human OP remains to be elusive.

miR-137 is a critical member of the miRNAs family, which has a length of around 20 nucleotides \[[@CR20], [@CR22]\]. Early in the year of 2008, J. Silber et al. indicated that miR-137 inhibited the proliferation of glioblastoma multiforme cells and induced differentiation of brain tumor stem cells \[[@CR20]\]. There is also other literature revealing that miR-137 is playing an important role in a variety of human cancers \[[@CR16], [@CR29]\]. In our preliminary experiments based on bioinformatics, we found that lncRNA FTX might bind with miR-137 in OP. Therefore, we are inspired to investigate whether FTX and miR-137 play a combined role in the development of OP. Previous studies have indicated that Notch signaling pathways have crucial roles in osteoclasts differentiation \[[@CR14], [@CR15]\]. Herein, we also examined if this signaling is involved in the development of OP. Thorough experiments and analysis were carried out to investigate the associations among lncRNA FTX, miR-137, and Notch1 signaling pathway.

Methods {#Sec2}
=======

Primary human samples {#Sec3}
---------------------

Patients with hip fractures at the third People's Hospital of Dongguan City were enrolled in this study, who were divided into 2 groups of OP patients and non-OP patients (control group). Osteoporosis were defined according to WHO criteria for classification of osteopenia and osteoporosis \[[@CR12]\]. To be included, the fracture of the patients must meet the definition of fragility fracture caused by falling or low energy instead of violence or high-energy traumata. Patients with liver and kidney diseases; osteoarthritis; metabolic bone disease, ovarian diseases or other endocrine diseases were excluded. Also, patients underwent hormone therapy in recent 3 months or other chronic corticosteroid use were excluded due to the influence of these drugs on lncRNA and miRNA expression. Postmenopausal women with OP fractures (*n* = 40) and healthy volunteers (*n* = 40) were selected, who received hip replacement surgery in the hospital. Supplementary file [2](#MOESM2){ref-type="media"} showed the patients' background regarding their age, gender, and BMI. RNA was extracted from the whole bone. According to the T-score of BMD, the patients were divided into two groups: the normal group (T-score ≥ − 1.0) and the OS group (T-score ≤ − 2.5). Serum and bone samples were placed in endoprosthesis. All patients signed informed consent. This research was approved by the Ethics Committee of the third People's Hospital of Dongguan City.

CD14 + PBMC culture {#Sec4}
-------------------

Peripheral blood mononuclear cells (PBMC) had extraction according to Sorensen et al. \[[@CR21]\]. CD14 antibody magnetic cell sorting (Miltenyi, Germany) was utilized to purify CD14 + PBMCs. CD14 + PBMCs were seeded in at 250, 000 cells/well. Cells were growing in alpha minimum essential medium (Invitrogen, USA) with 10% FBS (Gibco, CA), 50 IU/mL penicillin, and 50 mg/mL streptomycin, at 37 °C with humidity and 5% CO~2~. The culture medium was added in 25 ng/mL MCSF and 25 ng/mL RANKL (R&D Systems, USA).

Cell transfections {#Sec5}
------------------

FTX was amplified and purified. Then, pcDNA3.1 and FTX established the pcDNA-FTX recombinant plasmid and cloned to *E. coli*. The positive clones were selected and amplified. Next, recombinant plasmids were extracted and transfected to CD14 + PBMCs. For over-expression miR-137, CD14 + PBMCs were transfected with miR-137 mimic, or controls with Lipofectamine 2000 (Invitrogen, USA). All plasmids were made from Genepharma, China. At 48 h post-transfection, the cells were used for following experiments.

Cell proliferation assays {#Sec6}
-------------------------

4, 000 cells were seeded to a well from 96-well plate and cultured in alpha minimum essential medium with 10% FBS and antibiotics. 10 μL CCK-8 was added. We observed the signals at 2 h after the culture at 450 nm.

qRT-PCR {#Sec7}
-------

Total RNA was extracted by TRIzol (Invitrogen, USA). 0.5 μg RNA was reverse-transcribed by PrimeScript (Takara Bio, Japan). 1 μg cDNA was employed to detect mRNA expressions by qRT-PCR with SYBR Kit (Takara Bio, Japan). GAPDH and U6 were regarded as references. Primers sequences are in the below:

GAPDH (forward: 5′-TGGATTTGGACGCATTGGTC-3′ and reverse: 5′-TTTG.

CACTGGTACGTGTTGAT-3′);

TNFRSF1B (forward: 5′-CGGGCCAACATGCAAAA.

GTC-3′ and reverse: 5′-CAGATGCGGTTCTGTTCCC-3′);

ACP5 (forward: 5′-GACT.

GTGCAGATCCTGGGTG-3′ and reverse: 5′-GGTCAGAGAATACGTCCTCAAA.

G-3′);

MMP-9 (forward: 5′-TGTACCGCTATGGTTACACTCG-3′ and reverse: 5′-GG.

CAGGGACAGTTGCTTCT-3′);

MMP-2 (forward: 5′-TGACTTTCTTGGATCGGGT.

CG-3′ and reverse: 5′-AAGCACCACATCAGATGACTG-3′);

TRAP (forward: 5′-TC.

ACCCTGACCTATGGTGC-3′ and reverse: 5′-GCCGGACTCCAATGTTAAAGC-3′);

cathepsin K (forward: 5′-CTGGCTGGGGTTATGTCTCAA-3′ and reverse: 5′-GGCT.

ACGTCCTTACACACGAG-3′).

Luciferase reporter assays {#Sec8}
--------------------------

FTX-WT (wild-type), FTX-MUT (mutant), Notch1-WT, Notch1-MUT were designed via the clone of WT 3′UTR or MUT 3′UTR to pMir-reporter vector (Ambion, USA). CD14 + PBMCs had co-transfections with luciferase plasmid, miR-137 mimic or miR-NC by Lipofectamine 2000. Dual-luciferase reporter assays (Promega, USA) were used to identify their binding effects.

RNA pull-down assays {#Sec9}
--------------------

For pull-down assay, miR-137 without complementary sites with Notch1 was seen as internal reference (termed NC). MiR-137, miR-137-Mut, and NC were labeled with biotin to generate Bio-miR-137, BiomiR-137-Mut, and Bio-NC by GenePharma Company (Shanghai, China). Thereafter, they were transfected into CD14 + PBMCs. Forty-eight hours later, cells were harvested and incubated with Dynabeads M-280 Streptavidin (Invitrogen) for 10 min. After washing three times with buffer solution, the enrichments of bound RNAs were quantified and analyzed by qRT-PCR.

RNA immunoprecipitation (RIP) {#Sec10}
-----------------------------

RIP assay was performed using the RNA-Binding Protein Immunoprecipitation Kit (Millipore). Firstly, we lysed CD14 + PBMCs and incubated them with AGO2 antibody or IgG. RNA-protein complexes were immunoprecipitated with protein A agarose beads. Next, we extracted the RNAs using Trizol (Invitrogen, USA). The IP-western was employed to measure AGO2 protein and qRT-PCR was conducted to detect the mRNA expression of FTX, using RIPAb+ Ago2-RIP Validated Antibody and Primer Set, 03--110, Merck Millipore, US.

TRAP staining assay {#Sec11}
-------------------

Induced osteoclasts were fixed with 4% paraformaldehyde (PFA) for 20 min at room temperature and then stained by TRAP fluid for 1 h. TRAP solution was prepared by mixing acetate buer (pH 5.0), 50 mM sodium tartrate, naphthol AS-MX phosphate (Sigma Aldrich, Tokyo, Japan), and Fast Red Violet LB salt (Sigma Aldrich, Tokyo, Japan). After removal of the TRAP fluid, the plate was washed three times with phosphate-buffered saline (PBS). TRAP-positive multinuclear cells were observed using an inverted microscope.

Resorption pit assay {#Sec12}
--------------------

Mature osteoclasts were generated by coculturing of mouse bone marrow cells and osteoblasts with VitD3 (10 nM) on collagen gels for 6 days. The generated osteoclasts were replated on an Osteo Assay Surface plate (Corning, NY, USA), allowed to settle for 2 h, and then incubated with different concentrations of WESS for 24 h. After the incubation period, osteoclasts were visualized by TRAP staining. Resorption pits were photographed and analyzed by using Image J software, after removing cells by using sodium hypochlorite bleach.

Western blotting {#Sec13}
----------------

Protein was separated by 10% SDS-PAGE (Thermo, USA) and sent to PVDF membrane (Millipore, USA). The membrane was blocked by 5% BSA. Next, we treated the membranes with anti-Notch1 (1:1000, Abcam, UK), anti-GAPDH (1:1000, beyotime, China) at 4 °C for a night and then HRP-anti-rabbit (1:1000, beyotime, China) for 2 h at 25 C. We detected the signals using the ECL (Bio-Rad Lab, USA).

Flow cytometry {#Sec14}
--------------

After differentiation, cells were collected, washed and suspended. Then, it was incubated by Annexin V at 37 °C for 10 min, and stained by propidium iodide. Flow cytometer was employed to measure cell apoptosis.

Statistical analysis {#Sec15}
--------------------

All results were shown as mean ± SD, analyzed by SPSS 21.0. Differences between groups were conducted by Student's t-test (2 groups) and one-way ANOVA (\> 2 groups). *P*-value of \< 0.05 was considered to have significance.

Results {#Sec16}
=======

FTX was down-regulated and miR-137 was up-regulated in osteoporotic samples {#Sec17}
---------------------------------------------------------------------------

The expressions of FTX in serum and bone tissues of OP patients were analyzed. The expressions of FTX in patients' serum (*n* = 30) were down-regulated compared with control (*n* = 21) (Fig. [1](#Fig1){ref-type="fig"}a). It is negatively related to the miR-137 expressions (Fig. [1](#Fig1){ref-type="fig"}b). In addition, the expressions of FTX in patients' bone tissues (*n* = 7) were down-regulated compared with control (non-OP) (Fig. [1](#Fig1){ref-type="fig"}c) (*n* = 7). miR-137 was up-regulated in OP patients' bone tissues (Fig. [1](#Fig1){ref-type="fig"}d). Fig. 1FTX was down-regulated and miR-137 was up-regulated in osteoporotic samples. **a**. The FTX expressions in the serum of non-OP (healthy) (*n* = 21) and OP patients (*n* = 30). **b**. The relationship between FTX and miR-137 expressions in the serum of OP patients. **c**. The FTX expressions in the bone tissues of non-OP (healthy) (*n* = 7) and OP patients (*n* = 7). D. The miR-137 expressions in the bone tissues of non-OP (healthy) (*n* = 7) and OP patients (*n* = 7). \**p* \< 0.001

Over-expressions of FTX inhibited osteoclast differentiation {#Sec18}
------------------------------------------------------------

pcDNA-FTX was efficiently over-expressed successfully in CD14 + PBMCs, according to Fig. [2](#Fig2){ref-type="fig"}a. Figure [2](#Fig2){ref-type="fig"}b showed that osteoclast marker of TRAP, NFATC1, CTSK, and TRAF6 were hindered by FTX. Figures [2](#Fig2){ref-type="fig"}c-e demonstrated that the viabilities of CD14 + PBMCs were decreased by FTX, but cell apoptosis rate was promoted under FTX over-expressions. Figure [2](#Fig2){ref-type="fig"}f showed the experiments from TRAP-stained osteoclasts from each group, which revealed that pcDNA-FTX greatly inhibited osteoclast differentiation. It was obvious that FTX regulated osteoclast differentiation in CD14 + PBMCs. Fig. 2Over-expressions of FTX inhibited osteoclast differentiation. **a**. FTX mRNA levels under pcDNA-vector or pcDNA-FTX. **b**. qRT-PCR results of the expressions of TRAP, CTSK, and NFATC1, TRAF6 under pcDNA-vector or pcDNA-FTX. **c**, **d**, and **e**. Cell viability and cell apoptosis of CD14 + PBMCs in transfection with pcDNA-vector or pcDNA-FTX. **f**. TRAP-staining photos for osteoclast differentiation under transfection with pcDNA-vector or pcDNA-FTX. \**P* \< 0.001. *n* = 3

miR-137 was one of the targets of FTX in CD14 + PBMCs {#Sec19}
-----------------------------------------------------

Figure [3](#Fig3){ref-type="fig"}a predicted the shared binding sites between FTX and miR-137 using bioinformatics. It also showed the relevant sequences of FTX-WT, miR-137, and FTX-MUT. Figure [3](#Fig3){ref-type="fig"}b investigated the successful transfection of miR-137 in cells. Next, we conducted the experiments to study the interactions between miR-137 and FTX in OP by luciferase reporter assays and RIP assays in CD14 + PBMCs. RIP is a powerful method to investigate the physical associations between proteins and RNA molecules. Here, we utilized RIP experiment to verify the binding effect between FTX and miRNA. From Fig. [3](#Fig3){ref-type="fig"}c, miR-137 over-expressions resulted in a lower activity of FTX-WT. Figure [3](#Fig3){ref-type="fig"}d showed the RIP for binding effects between FTX and miR-137 with the AGO2 antibody. In contrast to the control IgG, higher FTX levels were found in the AGO2 antibody. Figure [3](#Fig3){ref-type="fig"}e revealed that over-expressions of FTX could down-regulate miR-137 mRNA expressions in CD14 + PBMCs. Fig. 3miR-137 was one of the targets of FTX in CD14 + PBMCs. **a**. The binding sites between miR-137 and FTX by Starbase. **b**. The miR-137 mRNA. **c**--**d**. Luciferase reporter assays and RIP assays for the interactions between miR-137 and FTX. **e**. The miR-137 mRNA expressions under the transfection of FTX. \**p* \< 0.001, *n* = 3

miR-137 mediated the effects of FTX on osteoclast differentiation {#Sec20}
-----------------------------------------------------------------

According to Fig. [4](#Fig4){ref-type="fig"}a, osteoclast-specific genes of TRAP, NFATC1, CTSK, and TRAF6 were all inhibited by FTX suppression, but this result was blunted by a miR-137 mimic. Figure [4](#Fig4){ref-type="fig"}b and c revealed that the viabilities of CD14 + PBMCs were mitigated by FTX but the effects were blunted by a miR-137 mimic. Cell apoptosis was promoted by FTX but the effects were blunted by a miR-137 mimic. Supplementary figure [1](#MOESM1){ref-type="media"}A showed the apoptotic rate for early apoptotic cells (LR), and late apoptotic cells (UR). It was noticed that late apoptotic cells appeared under the transfection of pcDNA-FTX. However, this effect was also attenuated by miR-137 (supplementary figure [1](#MOESM1){ref-type="media"}B). Figure [4](#Fig4){ref-type="fig"}d showed the experiments from TRAP-stained osteoclasts from each group, which revealed that pcDNA-FTX greatly inhibited osteoclast differentiation, while miR-137 mimic attenuated this effect. The data pointed out that FTX regulated osteoclast differentiation in CD14 + PBMCs. Fig. 4miR-137 mediated the effects of FTX on osteoclast differentiation. **a**. qRT-PCR for expressions of TRAP, CTSK, and NFATC1, TRAF6 CD14 + PBMCs. **b** and **c**. Cell viability and apoptosis by CCK-8 assays and flow cytometry. **d**. TRAP-staining photos for osteoclast differentiation under transfection with pcDNA-FTX or pcFTX+miR-137 mimic. **e**. Representative microscopic pictures of resorption pit\**P* \< 0.001. \*\**P* \< 0.001, *n* = 3

MiR-137 regulated the Notch1 signaling pathways in CD14 + PBMCs {#Sec21}
---------------------------------------------------------------

Figure [5](#Fig5){ref-type="fig"}a predicted the binding site in Notch1 and miR-137 using bioinformatics. It showed the relevant binding sequences of Notch-WT, miR-137, and Notch-MUT. From Fig. [5](#Fig5){ref-type="fig"}b, miR-137 over-expressions resulted in the decreased luciferase activity of Notch1-WT. Figure [5](#Fig5){ref-type="fig"}c showed the pull-down assays. We found that Notch1 was pulled-down via bio-miR-137 but not bio-NC or bio-miR-137-Mut. Figure [5](#Fig5){ref-type="fig"}d and e demonstrated that over-expressions of miR-137 could down-regulate Notch1 mRNA and protein expressions in CD14 + PBMCs, but over-expressions of FTX could up-regulate Notch1 these expressions. Fig. 5MiR-137 regulated the Notch1 signaling pathways in CD14 + PBMCs. **a**. The binding sites in miR-137 and Noch1. **b** and **c**. Luciferase assays and RNA pull-down assays for interactions between miR-137 and Notch1. **d** and **e**. The Notch1 mRNA and protein expressions under miR-137 mimic. **f** and **g**. Notch1 mRNA and protein expressions transfection of FTX. \**p* \< 0.001, \*\**P* \< 0.05, *n* = 3

The effects of miR-137 on osteoclast differentiation were mediated by Notch1 signaling pathways in CD14 + PBMCs {#Sec22}
---------------------------------------------------------------------------------------------------------------

To further illustrate the mechanisms underlying miR-137 and osteoclast differentiation, we evaluated the relative genes and cells in this process. The osteoclast-specific genes of TRAP, NFATC1, CTSK, and TRAF6 were all inhibited by miR137 suppression, but this result was blunted by shNotch (Fig. [6](#Fig6){ref-type="fig"}a). Furthermore, the viabilities of CD14 + PBMCs were mitigated by mirR-137 but the effects were blunted by a miR-137 mimic (Figs. [6](#Fig6){ref-type="fig"}b & c). Cell apoptosis was promoted by FTX but the effects were blunted by shNotch. Figure [6](#Fig6){ref-type="fig"}d showed the experiments from TRAP-stained osteoclasts from each group, which revealed that mir137 inhibitor greatly inhibited osteoclast differentiation, while shNotch attenuated this effect. Resorption pit assay also showed the same results (Fig. [6](#Fig6){ref-type="fig"}e.) The data pointed out that miR-137-notch regulated osteoclast differentiation in CD14 + PBMCs. Fig. 6The effects of miR-137 on osteoclast differentiation were mediated by Notch1 signaling pathways in CD14 + PBMCs. **a**. qRT-PCR for expressions of TRAP, CTSK, and NFATC1, TRAF6 CD14 + PBMCs. **b** and **c**. Cell viability and apoptosis by CCK-8 assays and flow cytometry. **d**. TRAP-staining photos for osteoclast differentiation under transfection with miR-137 inhibitor or miR-137 inhibitor+shNotch. **e**. Representative microscopic pictures of resorption pits. \**P* \< 0.001. \*\**P* \< 0.001, *n* = 3

Discussion {#Sec23}
==========

Previous studies have established that OP probably leads to the dysregulation of some specific lncRNAs and miRNAs \[[@CR3], [@CR24], [@CR25]\]. For example, Q. Wang et al. reported that the expressions of lncRNA MEG3 and miR-133a-3p were both up-regulated in OP samples \[[@CR25]\]. Based on our qRT-PCR results, the expressions of FTX in patients' serum was suppressed compared with control. Besides, it is negatively related to the expressions of miR-137. In addition, the expressions of FTX in patients' bone tissues were suppressed compared with control (non-OP) and miR-137 was up-regulated in OP patients' bone tissues. For the first time, we propose that FTX was suppressed and miR-137 was up-regulated in osteoporotic samples.

According to Q. Wang, the irregular expressions of related lncRNAs affect the osteogenic differentiation for OP patients \[[@CR25]\]. Another study in 2018 also demonstrated that specific lncRNA could inhibit osteoclasts differentiation \[[@CR23]\]. From our experiments, the osteoclast markers of TRAP, NFATC1, CTSK, and TRAF6 were all hindered by FTX. The viabilities of CD14 + PBMCs were decreased by FTX, but cell apoptosis rate was promoted under FTX over-expressions. It was obvious that FTX regulated osteoclast differentiation in CD14 + PBMCs. Similar to previous researches, we found that over-expressions of FTX inhibited osteoclast differentiation.

It was commonly known that lncRNAs and miRNAs could bind to each other and exert biological functions in multiple types of human cancers \[[@CR5], [@CR9]\]. Firstly, our study from bioinformatics predicted the shared binding sites between FTX and miR-137. The luciferase reporter assays and RIP assays also confirmed the close interactions between miR-137 and FTX in CD14 + PBMCs. Moreover, over-expressions of FTX could suppress miR-137 mRNA expressions in CD14 + PBMCs. As far as we know, we are the first to report that miR-137 was directly targeted by FTX in CD14 + PBMCs.

The interactions between lncRNAs and miRNAs may reverse the biological effects resulted from lncRNAs \[[@CR10], [@CR27]\]. In consistence with previous studies, we noticed that osteoclast-specific genes of TRAP, NFATC1, CTSK, and TRAF6 were all inhibited by FTX suppression, but this result was blunted by a miR-137 mimic. Moreover, the viabilities of CD14 + PBMCs were mitigated by FTX but the effects were blunted by a miR-137 mimic. Cell apoptosis was promoted by FTX but the effects were blunted by a miR-137 mimic. Consistent with the well-established theories, our studies revealed that FTX regulated osteoclast differentiation in CD14 + PBMCs, while miR-137 mediated the effects of FTX on osteoclast differentiation.

A variety of researches have demonstrated the essential effects of a Notch signaling pathway in both bone remodeling \[[@CR1], [@CR19]\] and OP \[[@CR4], [@CR14]\]. In our experiments, miR-137 over-expressions resulted in the decreased luciferase activity of Notch1-WT. Notch1 was pulled down by bio-miR-137 but not bio-NC or bio-miR-137-Mut. Over-expressions of miR-137 could suppress Notch1 mRNA and protein expressions in CD14 + PBMCs, but over-expressions of FTX could up-regulate Notch1 these expressions. As a novel finding, miR-137 regulated the Notch1 signaling pathway in CD14 + PBMCs.

Conclusion {#Sec24}
==========

FTX was suppressed in OP samples and serums, however, miR-137 was greatly elevated. FTX reduced osteoclast-genesis and inhibited osteogenic differentiation by targeting miR-137, which inhibited the Notch1 signaling pathway. Our experiments and results pointed out that lncRNA FTX up-regulated miR-137 in OP by Notch1 signaling pathway.
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**Additional file 1: Figure S1.** Apoptosis rate for UR and LR. A. The apoptotic rate for early apoptotic cells (LR), and late apoptotic cells (UR) under transfection of pcDNA-FTX and pcDNA-vector. B. The apoptotic rate for LR, and UR under transfection of pcDNA-FTX and pcFTX+miR-137 mimic.
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